Latest News

Date Title Topic
27 Mar 2015 ESMO Press Release: Clinical Trial Design in the Era of Targeted Therapies
25 Mar 2015 EMA's Pharmacovigilance Risk Assessment Committee Recommends Further Measures to Minimise Risk of Osteonecrosis of the Jaw with Bisphosphonate Medicine Palliative and supportive care
24 Mar 2015 TAT 2015 Meeting Resources
Pre-IMPAKT 2015 Training Course
12 Mar 2015 FDA Approves First Therapy for High-Risk Neuroblastoma Cancer in Special Situations - Anticancer agents & Biologic therapy
10 Mar 2015 Rare Cancers Europe Press Release: Improving the Organisation of Healthcare for Rare Cancer Patients
06 Mar 2015 ESMO South-East Asia Summit: Meeting Resources
04 Mar 2015 Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas Translational research - Gastrointestinal cancers
03 Mar 2015 ICHNO 2015: Meeting Resources
27 Feb 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Ceritinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 Mar 2015 Adjuvant VEGF Inhibitors, Sorafenib or Sunitinib, do not Improve Outcomes in Resected Locally-Advanced Renal Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
20 Feb 2015 New HPV Vaccine Offers Greater Protection Against Cervical Cancer Than Current Vaccine Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies
19 Feb 2015 ESMO is Hiring
18 Feb 2015 Genomic Profiling of Cancer of Unknown Primary Site Translational research - Carcinoma of unknown primary site